Status:
UNKNOWN
Helicobacter Pylori Eradication and Irritable Bowel Syndrome: A Prospective Study
Lead Sponsor:
Assiut University
Conditions:
Irritable Bowel Syndrome
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
H. Pylori is frequently observed in patients with irritable bowel syndrome(IBS). However, the effect of H. pylori eradication on IBS is not clear.
Detailed Description
Patients with IBS symptoms using Rome IV criteria will be included. Testing for H. pylori will be done. Patients with H. pylori will receive triple therapy and followed after two weeks for eradication...
Eligibility Criteria
Inclusion
- Patients newly diagnosed with IBS and H.pylori
Exclusion
- Patients received previous treatment of H.pylori
- Patients receiving treatment for IBS.
Key Trial Info
Start Date :
August 10 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 10 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04512898
Start Date
August 10 2020
End Date
November 10 2020
Last Update
August 14 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.